Carnitine shuttle enzyme

The carnitine shuttle is a mitochondrial transport mechanism required for the entry of long-chain fatty acids into the mitochondrial matrix, where β-oxidation occurs to generate cellular energy. It comprises three main protein components: Carnitine palmitoyltransferase 1 (CPT1), located on the outer mitochondrial membrane, which forms acyl-carnitine from acyl-CoA; Carnitine-acylcarnitine translocase (CACT/SLC25A20), which exchanges acyl-carnitine for free carnitine across the inner mitochondrial membrane; and Carnitine palmitoyltransferase 2 (CPT2), located on the matrix side of the inner membrane, which regenerates acyl-CoA from acyl-carnitine. Deficiency or inhibition of any of these enzymes impairs fatty acid oxidation and energy homeostasis, leading to metabolic diseases and secondary involvement in cardiovascular and neuromuscular conditions. The system can be modulated by pharmacological agents such as CPT inhibitors or supplemented with L-carnitine in deficiency states. Because "Carnitine shuttle enzymes" is not a specific entity but rather a pathway descriptor, for precise drug targeting or molecular study, individual components (e.g., CPT1, CACT, CPT2) should be specified[2][4][8][9][10].

Other names

carnitine shuttle systemfatty acid mitochondrial transport enzymesCPT system

Inhibition of fatty acid import into mitochondria (CPT1/2 inhibitors) Modulation of β-oxidation Enhancement of fatty acid metabolism (carnitine supplementation)